These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 12629696

  • 21. [Adenosine deaminase and nucleoside phosphorylase: a new approach to the etiopathogenesis of various immunologic deficiencies].
    Lucivero G, Dammacco F, Bonomo L.
    Recenti Prog Med; 1977 Sep; 63(3):275-88. PubMed ID: 413174
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Structure of human PNP complexed with ligands.
    Canduri F, Silva RG, dos Santos DM, Palma MS, Basso LA, Santos DS, de Azevedo WF.
    Acta Crystallogr D Biol Crystallogr; 2005 Jul; 61(Pt 7):856-62. PubMed ID: 15983407
    [Abstract] [Full Text] [Related]

  • 24. [Purine nucleoside phosphorylase].
    Pogosian LG, Akopian ZhI.
    Biomed Khim; 2013 Jul; 59(5):483-97. PubMed ID: 24479338
    [Abstract] [Full Text] [Related]

  • 25. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T, Gruchalska E.
    Acta Haematol Pol; 1979 Jul; 10(3):205-10. PubMed ID: 116467
    [No Abstract] [Full Text] [Related]

  • 26. Purine nucleoside phosphorylase inhibition as a novel therapeutic approach for B-cell lymphoid malignancies.
    Furman RR, Hoelzer D.
    Semin Oncol; 2007 Dec; 34(6 Suppl 5):S29-34. PubMed ID: 18086344
    [Abstract] [Full Text] [Related]

  • 27. [PNP (purine nucleoside phosphorylase) deficiency].
    Taniguchi A.
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():372-6. PubMed ID: 12629750
    [No Abstract] [Full Text] [Related]

  • 28. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM, Mitchell BS, Daddona PE, Kelley WN.
    J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
    [Abstract] [Full Text] [Related]

  • 29. Inhibitors of purine nucleoside phosphorylase: effects of 9-deazapurine ribonucleosides and synthesis of 5'-deoxy-5'-iodo-9-deazainosine.
    Stoeckler JD, Ryden JB, Parks RE, Chu MY, Lim MI, Ren WY, Klein RS.
    Cancer Res; 1986 Apr; 46(4 Pt 1):1774-8. PubMed ID: 3081256
    [Abstract] [Full Text] [Related]

  • 30. Inherited biochemical defects in lymphocytes causing immunodeficiency disease.
    Giblett ER.
    Prog Clin Biol Res; 1981 Apr; 58():123-34. PubMed ID: 6267616
    [No Abstract] [Full Text] [Related]

  • 31. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
    Miles RW, Tyler PC, Furneaux RH, Bagdassarian CK, Schramm VL.
    Biochemistry; 1998 Jun 16; 37(24):8615-21. PubMed ID: 9628722
    [Abstract] [Full Text] [Related]

  • 32. Metabolic defects and immunodeficiency disorders.
    Hirschhorn R.
    N Engl J Med; 1983 Mar 24; 308(12):714-6. PubMed ID: 6402701
    [No Abstract] [Full Text] [Related]

  • 33. Purine nucleoside phosphorylase deficiency associated with a fatal lymphoproliferative disorder.
    Watson AR, Evans DI, Marsden HB, Miller V, Rogers PA.
    Arch Dis Child; 1981 Jul 24; 56(7):563-5. PubMed ID: 6791594
    [Abstract] [Full Text] [Related]

  • 34. Purine nucleoside phosphorylase deficiency.
    Markert ML.
    Immunodefic Rev; 1991 Jul 24; 3(1):45-81. PubMed ID: 1931007
    [Abstract] [Full Text] [Related]

  • 35. Synthesis and evaluation of the substrate activity of C-6 substituted purine ribosides with E. coli purine nucleoside phosphorylase: palladium mediated cross-coupling of organozinc halides with 6-chloropurine nucleosides.
    Hassan AE, Abou-Elkhair RA, Riordan JM, Allan PW, Parker WB, Khare R, Waud WR, Montgomery JA, Secrist JA.
    Eur J Med Chem; 2012 Jan 24; 47(1):167-74. PubMed ID: 22112758
    [Abstract] [Full Text] [Related]

  • 36. [Escherichia coli K-12 mutants capable of catabolizing purine nucleosides in the absence of purine nucleoside phosphorylase].
    Kocharian ShM, Smirnov IuV.
    Genetika; 1977 Jan 24; 13(8):1425-33. PubMed ID: 410701
    [Abstract] [Full Text] [Related]

  • 37. Purine nucleoside phosphorylase deficiency (PNP-def) presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation.
    Myers LA, Hershfield MS, Neale WT, Escolar M, Kurtzberg J.
    J Pediatr; 2004 Nov 24; 145(5):710-2. PubMed ID: 15520787
    [Abstract] [Full Text] [Related]

  • 38. Molecular modeling and dynamics simulations of PNP from Streptococcus agalactiae.
    Caceres RA, Saraiva Timmers LF, Dias R, Basso LA, Santos DS, de Azevedo WF.
    Bioorg Med Chem; 2008 May 01; 16(9):4984-93. PubMed ID: 18381241
    [Abstract] [Full Text] [Related]

  • 39. [Congenital immunodeficiency with adenosine deaminase and purine nucleoside phosphorylase deficiency].
    Sakura N, Usui T, Ito K.
    Nihon Rinsho; 1977 Aug 10; 35(8):2564-80. PubMed ID: 411964
    [No Abstract] [Full Text] [Related]

  • 40. Purine nucleoside phosphorylase deficiency: a molecular model for selective loss of T cell function.
    Ochs UH, Chen SH, Ochs HD, Osborne WR, Scott CR.
    J Immunol; 1979 Jun 10; 122(6):2424-9. PubMed ID: 109531
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.